Article
Artificial intelligence-driven integration of multi-biofluid omics and clinical phenotype enables stratification of endometrial cancer.
Cell reports. Medicine - 16 Jun 2026
Li Dandan, Wu Pengfei, Zheng Jianxujie, Yang Yunhan, Shan Weiwei, Yi Jia, Zhao Dan, Yang Shijun, Hu Yiwei, Zhu Xinying, Fan Ruibin, Fu Pengxiao, Bai Chenqi, Chen Xiaojun, Qiao Liang
Abstract excerpt
Endometrial cancer (EC) incidence is rising, yet current diagnostics lack precision and scalability. We develop an artificial intelligence (AI)-based platform integrating multi-biofluid omics and clinical data for EC stratification. Using two independent cohorts from different clinical centers (531 participants for model development, 204 for external validation), we collect 1,179 samples (plasma, cervical/uterine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
